A Rare Blood Disorder Treated for Decades with Steroids Alone Now Has Its First FDA Approved Therapy

An Approval That Fills a Longstanding Treatment Gap

The Food and Drug Administration has approved Imaavy, known generically as nipocalimab-aahu, for warm autoimmune hemolytic anemia in adults and children 12 and older who are currently being treated with corticosteroids or have previously been treated with corticosteroids. It is the first therapy proven safe and effective specifically for the condition.